Convalescent plasma, the use of survivors' antibodies transfused into sick COVID-19 patients is safe and significantly improves clinical outcomes when using high levels of antibodies, according to a new publication by scientists at ...
The Hackensack Meridian Center for Discovery and Innovation (CDI) has announced a research collaboration with Merck to investigate drugs for treating COVID-19.